The “Born in Guangzhou Cohort Study” is looking to recruit 50,000 baby-mother sets by 2020. Since 2012, 1.6 million samples have been collected for the project and the some of the first findings have been published.
A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa’s poorest regions.
Studies of breast cancer do not take sufficient account of patients’ race, ethnicity, economic status, education level, health insurance coverage, and other social factors, a group of scientists argue.
Researchers have developed a type of personalised machine learning that helps robots estimate the engagement and interest of each a child during autism therapy, using data that are unique to that child.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.
New research suggests that the level of testosterone in an adult man is largely determined by the stress they encounter during their childhood, challenging the idea that testosterone production is controlled by genetics.
The U.S. Food and Drug Administration has approved the first drug derived from Marijuana to treat two rare and severe forms of epilepsy. Will the U.K. follow?
There’s no therapy developed yet, that can stop cancer cells from moving throughout the body. New research shows that it may be possible to do so, in freezing cancer cells and killing them where they stand.
Researchers from the Mayo Clinic recommends genetic testing for all pancreatic cancer patients as the new standard of care, after finding six genetic mutations in patients with no family history of the disease.
When it comes to understanding what makes people tick—and get sick—medical science has long assumed that the bigger the sample of human subjects, the better. New research suggests this big data approach may be wildly off the mark.